Program

IT Symposium - Wednesday, November 12 Time Topic Speaker / Moderator 12:00 p.m. Registration 1:00 Welcome Raju Kucherlapati, Ph.D. Scientific Director Emeritus, Harvard Medical School-Partners HealthCare Center for Genetics and Genomics, Paul C. Cabot Professor of Genetics, Professor of Medicine, Harvard Medical School 1:05 Keynote Talk David J. Brailer, M.D., Ph.D. Founder, Health Evolution Partners (Former National Coordinator for Health Information Technology, U.S. Department of Health and Human Services) Introducer: Diane Keogh Corporate Director, Research Computing, Partners HealthCare 1:40 Panel 1: Genetics into the Healthcare Enterprise Moderator: John P. Glaser, Ph.D. Vice President and Chief Information Officer, Partners HealthCare Lionel Binns Business Development Executive, Emerging Markets, Worldwide Health and Life Sciences, Technology Solutions Group, Hewlett-Packard Company Neil de Crescenzo Senior Vice President and General Manager, Healthcare and Life Sciences, Oracle Corporation Janet Dillione Chief Executive Officer, Health Services, Siemens Medical Solutions Eiry W. Roberts, MB (Hons) BS MRCP FFPM Vice President, Transitional Phase Development, Eli Lilly and Company 2:40 Break 3:10 Panel 2: Business Outlook Moderator: Thomas J. Miller Chief Executive Officer, Workflow and Solutions, Siemens Healthcare George M. Church, Ph.D. Professor of Genetics, Harvard Medical School, Director, Center for Computational Genetics James Heywood Chairman and Co-Founder, PatientsLikeMe Frederick S. Lee, M.D., M.P.H. Product Manager for Personalized Medicine and Genomics, McKesson Corp. Eiry W. Roberts, M.D. Vice President, Project/Program Medical, Eli Lilly and Company Steven St. Peter, M.D., M.B.A. Managing Director, MPM Capital 4:15 Panel 3: IT in Personalized Genomics Moderator: Samuel J. Aronson Executive Director of Information Technology, Harvard-Partners Center for Genetics and Genomics Linda Avey Co-Founder, 23andMe Jorge Conde Co-Founder and Chief Executive Officer, Knome, Inc. David P. King Chief Executive Officer, LabCorp Dietrich Stephan, Ph.D. Co-founder and Chief Science Officer, Navigenics 5:15 Closing Raju Kucherlapati, Ph.D. Scientific Director Emeritus, Harvard Medical School-Partners HealthCare Center for Genetics and Genomics, Paul C. Cabot Professor of Genetics, Professor of Medicine, Harvard Medical School Main Conference - Thursday, November 13 Time Topic Speaker / Moderator 7:30 a.m. Registration & Continental Breakfast 8:45 Welcome Raju Kucherlapati, Ph.D. Scientific Director Emeritus, Harvard Medical School-Partners HealthCare Center for Genetics and Genomics, Paul C. Cabot Professor of Genetics, Professor of Medicine, Harvard Medical School 9:00 Keynote Talk Clayton M. Christensen, D.B.A. Robert and Jane Cizik Professor of Business Administration, Harvard Business School Introducer: Sandra Glucksmann, Ph.D. Senior Vice President, Tempo Pharmaceuticals Keynote Talk Richard M.J. Bohmer, MBChB, MPH MBA Class of 1973 Senior Lecturer of Business Administration, Harvard Business School Introducer: Robert I. Tepper, M.D. Partner, Third Rock Ventures, LLC Conversation with Keynote Speakers Moderator: Richard G. Hamermesh, D.B.A. MBA Class of 1961 Professor of Management Practice, Harvard Business School 10:30 Break 11:15 Session I: Evidence-Based Medicine Introducer: Christine Seidman, M.D. Investigator, Howard Hughes Medical Institute, Thomas W. Smith Professor of Medicine and Genetics, Harvard Medical School, Director, Cardiovascular Genetics Center, Brigham and Women's Hospital Moderator: Mason W. Freeman, M.D. Chief, Lipid Metabolism Unit, Massachusetts General Hospital, Harvard Medical School Mark A. Creager, M.D. Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School Felix W. Frueh, Ph.D. Vice President, R&D Personalized Medicine, Medco Health Solutions Matthew P. Goetz, M.D. Assistant Professor of Oncology, Assistant Professor of Pharmacology, Mayo Clinic Peter G. Traber, M.D. President & CEO, Baylor College of Medicine 12:30 p.m. Break 1:00 Luncheon & Keynote Talk The Lord Naren Patel The House of Lords, United Kingdom Introducer: Joanne C. Armstrong, M.D. Senior Medical Director for Women's Health and Clinical Lead for Genomics, Aetna, Inc. 2:00 Table Discussions Facilitators: Robert C. Wells Partner, Health Futures, LLC Harry Glorikian Managing Partner, Scientia Advisors Mollie Roth, Esq. Corporate Counsel, VP, Business Development, Diaceutics 3:00 Break 3:15 Keynote Talk Aidan C. Power, MB BCh MSc MRCPsych Vice President & Global Head of Molecular Medicine, Pfizer Global Research and Development Introducer: Nadine Cohen, Ph.D. Head of Pharmacogenomics and Senior Research Fellow, Johnson & Johnson Pharmaceutical Research and Development East Coast and Europe 3:45 Session II: Drugs & Treatment Moderator: Deborah Dunsire, M.D. President and CEO, Millennium: The TAKEDA Oncology Company David D. Chang, M.D., Ph.D. Vice President, Global Oncology Development, Amgen Bruce E. Johnson, M.D. Director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Professor of Medicine, Harvard Medical School, Brigham and Women's Hospital 5:00 Reception Main Conference - Friday, November 14 Time Topic Speaker / Moderator 7:15 a.m. Continental Breakfast 8:15 Keynote Talk Personalized Medicine Coalition's Fourth Annual Award for Leadership in Personalized Medicine The Hon. Michael O. Leavitt Secretary of Health and Human Services, U.S. Department of Health and Human Services Introducer: James J. Mongan, M.D. President and Chief Executive Officer, Partners HealthCare Award Background: Edward Abrahams, Ph.D. Executive Director, Personalized Medicine Coalition Presenter: Mara G. Aspinall Senior Advisor, Genzyme Corporation, Dana-Farber Cancer Institute 9:15 Session III: Government & Regulators Moderator: M. Kathleen Behrens, Ph.D. General Partner, RS Investments, Member, President's Council of Advisors on Science and Technology (PCAST) Arthur A. Daemmrich, Ph.D Assistant Professor of Business Administration, Harvard Business School Gregory Downing, D.O., Ph.D. Program Director, Personalized Health Care, U.S. Department of Health and Human Services Lawrence J. Lesko, Ph.D., FCP Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration Michael Paul, Ph.D. President and CEO, LineaGen 10:30 Break 11:00 Session IV: Reimbursement Moderator: Samuel R. Nussbaum, M.D. Executive Vice President and Chief Medical Officer, Wellpoint, Inc. Mara G. Aspinall Senior Advisor, Genzyme Corporation, Dana-Farber Cancer Institute Robert S. Epstein, M.D., M.S. Senior Vice President, Medical & Analytical Affairs, and Chief Medical Officer, Medco Health Solutions, Inc. Carol J. McCall, FSA MAAA Vice President, Research and Development, Humana Inc. Margaret Piper, Ph.D., M.P.H. Associate Director, Blue Cross/Blue Shield, Association Technology Evaluation Center 12:15 Town Hall Meeting Facilitators: Robert C. Wells Partner, HealthFutures, LLC Harry Glorikian Managing Partner, Scientia Advisors Mollie Roth, Esq. Corporate Counsel, VP, Business Development, Diaceutics 1:15 Closing Raju Kucherlapati, Ph.D. Scientific Director Emeritus, Harvard Medical School-Partners HealthCare Center for Genetics and Genomics, Paul C. Cabot Professor of Genetics, Professor of Medicine, Harvard Medical School 1:30 p.m. Bag Lunch